XML 22 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Series A
Series B
Preferred Shares of Beneficial Interest Series A
Preferred Shares of Beneficial Interest Series A
Series A
Common Shares of Beneficial Interest
Common Shares of Beneficial Interest
Cumulative Effect, Period of Adoption, Adjustment
Paid-in Capital
Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Paid-in Capital
Series A
Accumulated Deficit and Distributions in Excess of Net Earnings
Accumulated Deficit and Distributions in Excess of Net Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit and Distributions in Excess of Net Earnings
Series A
Accumulated Deficit and Distributions in Excess of Net Earnings
Series B
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Cumulative Effect, Period of Adoption, Adjustment
Noncontrolling Interest
Noncontrolling Interest
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2017         125   69,370,609                        
Beginning balance at Dec. 31, 2017 $ (186,924)       $ 0   $ 694   $ 394,082     $ (581,470)       $ (230)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Net (loss) income 47,985                     47,985              
Other comprehensive income (loss) (9,492)                             (9,492)      
Distribution on preferred shares of beneficial interest - Series A     $ (134)               $ (133)     $ (1)          
Distribution on preferred shares of beneficial interest - Series A (in shares)           (125)                          
Distributions on preferred shares of beneficial interest - Series B       $ (1,817)                     $ (1,817)        
Distributions on common shares of beneficial interest (104,976)                     (104,976)              
Share-based compensation expense 8,556               8,556                    
Share-based compensation expense (modification of Restricted Stock Units) 2,042               2,042                    
Common share issuance related to share-based payment plans, net of shares withheld for employee taxes 2,667           $ 18   2,649                    
Common stock issuance related to share-based payment plans, net of shares withheld for employee taxes (in shares)             1,847,274                        
Warrants exercise 0           $ 64   (64)                    
Warrants exercise (in shares)             6,426,818                        
Issuance of common shares 577,338           $ 374   576,964                    
Issuance of common shares (in shares)             37,350,000                        
Conversion of mezzanine Series B Preferred shares 372,791           $ 332   372,459                    
Conversion of Series B Preferred shares (in shares)             33,240,258                        
Other (1,281)               (422)     1,934       (2,793)      
Ending balance (in shares) at Dec. 31, 2018         0   148,234,959                        
Ending balance at Dec. 31, 2018 706,755       $ 0   $ 1,482   1,356,133     (638,345)       (12,515)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Net (loss) income 48,162                     48,162              
Other comprehensive income (loss) (1,611)                             (1,611)      
Distributions on common shares of beneficial interest (146,590)                     (146,590)              
Share-based compensation expense 12,822               12,822                    
Share-based compensation expense (modification of Restricted Stock Units) 3,044               3,044                    
Common share issuance related to share-based payment plans, net of shares withheld for employee taxes 3,476           $ 15   3,461                    
Common stock issuance related to share-based payment plans, net of shares withheld for employee taxes (in shares)             1,502,450                        
Issuance of common shares 1,207,048           $ 421   1,206,627                    
Issuance of common shares (in shares)             42,062,500                        
Other (88)               0     (88)       0      
Ending balance (in shares) at Dec. 31, 2019             191,799,909                        
Ending balance at Dec. 31, 2019 1,833,018 $ (500)         $ 1,918 $ 0 2,582,087 $ 0   (736,861) $ (500)     (14,126) $ 0 $ 0 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Net (loss) income 24,555                     24,540           15  
Other comprehensive income (loss) 9,751                             9,747   4  
Distributions on common shares of beneficial interest (182,941)                     (182,700)           (241)  
Share-based compensation expense 17,862               15,259                 2,603  
Common share issuance related to share-based payment plans, net of shares withheld for employee taxes 292           $ 6   286                    
Common stock issuance related to share-based payment plans, net of shares withheld for employee taxes (in shares)             574,599                        
Issuance of common shares 1,578,659           $ 451   1,578,208                    
Issuance of common shares (in shares)             45,161,428                        
Issuance of common shares as consideration in the Agro acquisition 512,125           $ 142   511,983                    
Issuance of common shares as consideration in the Argo acquisition (in shares)             14,166,667                        
Ending balance (in shares) at Dec. 31, 2020             251,702,603                        
Ending balance at Dec. 31, 2020 $ 3,792,821           $ 2,517   $ 4,687,823     $ (895,521)       $ (4,379)   $ 2,381